3,4-Methylenedioxymethamphetamine, mephedrone, and β-phenylethylamine release dopamine from the cytoplasm by means of transporters and keep the concentration high and constant by blocking reuptake
- PMID:30172789
- DOI: 10.1016/j.ejphar.2018.08.037
3,4-Methylenedioxymethamphetamine, mephedrone, and β-phenylethylamine release dopamine from the cytoplasm by means of transporters and keep the concentration high and constant by blocking reuptake
Abstract
The addiction-related behavioural effects of drugs of abuse are mediated by the mesocorticolimbic monoamine systems. We investigated the effects of 3,4-methylenedioxymethamphetamine (MDMA), mephedrone, β-phenylethylamine (β-PEA) methylphenidate (MPH) on dopamine release from mouse perfused nucleus accumbens and prefrontal cortex slices. The fractional release of [3H]-dopamine was measured at rest and in response to field stimulation. The distributions of [3H]-dopamine and its metabolites were determined using high-pressure liquid chromatography. The effect of drugs on [3H]-dopamine uptake was measured in synaptosomal P2 preparations from the frontal cortex and striatum. Similar to MDMA, mephedrone β-PEA increased the resting release of [3H]-dopamine from the nucleus accumbens and prefrontal cortex in a [Ca2+]o-independent manner, and the stimulation-evoked release was also augmented. In contrast, MPH failed to affect the resting release but potentiated the release in response to axonal activity. Similar to dopamine transporter antagonist GBR 12909, mephedrone, MDMA and MPH biphasically inhibited the [3H]-dopamine uptake. The administration of GBR 12909 and nisoxetine, or lowering the bath temperature prevented MDMA, mephedrone and β-PEA from enhancing the resting, cytoplasmic release of [3H]-dopamine, indicating the role of transporters in the release process. We conclude that amphetamine-like drugs of abuse and the trace amine β-PEA excessively increase the [Ca2+]o-independent, non-vesicular release of dopamine from the cytoplasm into the extrasynaptic space and inhibit the high-affinity transporters, thereby maintaining a high ambient, non-synaptic concentration of dopamine that may tonically control the activity of neurons equipped with dopamine receptors and is likely involved in the reinforcing effects and abusive potential of amphetamines.
Keywords: Dopamine; MDMA; Mephedrone; Methylphenidate; Release; β-phenylethylamine.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
- Contribution of analog signaling to neurotransmitter interactions and behavior: Role of transporter-mediated nonquantal dopamine release.Román V, Kedves R, Kelemen K, Némethy Z, Sperlágh B, Lendvai B, Vizi ES.Román V, et al.Physiol Rep. 2021 Nov;9(21):e15088. doi: 10.14814/phy2.15088.Physiol Rep. 2021.PMID:34762352Free PMC article.
- The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.Pifl C, Reither H, Hornykiewicz O.Pifl C, et al.Eur J Pharmacol. 2015 May 15;755:119-26. doi: 10.1016/j.ejphar.2015.03.004. Epub 2015 Mar 11.Eur J Pharmacol. 2015.PMID:25771452
- Effect of beta-phenylethylamine on extracellular concentrations of dopamine in the nucleus accumbens and prefrontal cortex.Murata M, Katagiri N, Ishida K, Abe K, Ishikawa M, Utsunomiya I, Hoshi K, Miyamoto K, Taguchi K.Murata M, et al.Brain Res. 2009 May 7;1269:40-6. doi: 10.1016/j.brainres.2009.03.002. Epub 2009 Mar 11.Brain Res. 2009.PMID:19285043
- The preclinical pharmacology of mephedrone; not just MDMA by another name.Green AR, King MV, Shortall SE, Fone KC.Green AR, et al.Br J Pharmacol. 2014 May;171(9):2251-68. doi: 10.1111/bph.12628.Br J Pharmacol. 2014.PMID:24654568Free PMC article.Review.
- Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.Gudelsky GA, Yamamoto BK.Gudelsky GA, et al.Pharmacol Biochem Behav. 2008 Aug;90(2):198-207. doi: 10.1016/j.pbb.2007.10.003. Epub 2007 Oct 16.Pharmacol Biochem Behav. 2008.PMID:18035407Free PMC article.Review.
Cited by
- Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy.Oeri HE.Oeri HE.J Psychopharmacol. 2021 May;35(5):512-536. doi: 10.1177/0269881120920420. Epub 2020 Sep 10.J Psychopharmacol. 2021.PMID:32909493Free PMC article.Review.
- A review on the mitochondrial toxicity of "ecstasy" (3,4-methylenedioxymethamphetamine, MDMA).Capela JP, Carvalho FD.Capela JP, et al.Curr Res Toxicol. 2022 May 19;3:100075. doi: 10.1016/j.crtox.2022.100075. eCollection 2022.Curr Res Toxicol. 2022.PMID:35651589Free PMC article.
- Transition metal ions and neurotransmitters: coordination chemistry and implications for neurodegeneration.Yoo J, Han J, Lim MH.Yoo J, et al.RSC Chem Biol. 2023 Jun 27;4(8):548-563. doi: 10.1039/d3cb00052d. eCollection 2023 Aug 3.RSC Chem Biol. 2023.PMID:37547459Free PMC article.Review.
- Roles Played by the Na+/Ca2+ Exchanger and Hypothermia in the Prevention of Ischemia-Induced Carrier-Mediated Efflux of Catecholamines into the Extracellular Space: Implications for Stroke Therapy.Lakatos M, Baranyi M, Erőss L, Nardai S, Török TL, Sperlágh B, Vizi ES.Lakatos M, et al.Neurochem Res. 2020 Jan;45(1):16-33. doi: 10.1007/s11064-019-02842-0. Epub 2019 Jul 25.Neurochem Res. 2020.PMID:31346893Free PMC article.
- The Pharmacological Effects of Phenylephrine are Indirect, Mediated by Noradrenaline Release from the Cytoplasm.Al-Khrasani M, Karadi DA, Galambos AR, Sperlagh B, Vizi ES.Al-Khrasani M, et al.Neurochem Res. 2022 Nov;47(11):3272-3284. doi: 10.1007/s11064-022-03681-2. Epub 2022 Aug 9.Neurochem Res. 2022.PMID:35945308Free PMC article.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous